- Home
- CLNN vs CLDI Comparison
CLNN vs CLDI Comparison
Compare CLNN & CLDI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLNN
- CLDI
- Stock Information
- Founded
- CLNN 2012
- CLDI 2014
- Country
- CLNN United States
- CLDI United States
- Employees
- CLNN N/A
- CLDI N/A
- Industry
- CLNN Biotechnology: Pharmaceutical Preparations
- CLDI Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CLNN Health Care
- CLDI Health Care
- Exchange
- CLNN Nasdaq
- CLDI Nasdaq
- Market Cap
- CLNN 23.1M
- CLDI 20.2M
- IPO Year
- CLNN N/A
- CLDI N/A
- Fundamental
- Price
- CLNN $3.82
- CLDI $5.04
- Analyst Decision
- CLNN Strong Buy
- CLDI
- Analyst Count
- CLNN 5
- CLDI 0
- Target Price
- CLNN $40.00
- CLDI N/A
- AVG Volume (30 Days)
- CLNN 70.5K
- CLDI 992.7K
- Earning Date
- CLNN 08-19-2025
- CLDI 08-08-2025
- Dividend Yield
- CLNN N/A
- CLDI N/A
- EPS Growth
- CLNN N/A
- CLDI N/A
- EPS
- CLNN N/A
- CLDI N/A
- Revenue
- CLNN $350,000.00
- CLDI N/A
- Revenue This Year
- CLNN N/A
- CLDI N/A
- Revenue Next Year
- CLNN $1,753.57
- CLDI N/A
- P/E Ratio
- CLNN N/A
- CLDI N/A
- Revenue Growth
- CLNN N/A
- CLDI N/A
- 52 Week Low
- CLNN $2.28
- CLDI $2.43
- 52 Week High
- CLNN $6.90
- CLDI $46.68
- Technical
- Relative Strength Index (RSI)
- CLNN 55.42
- CLDI 41.12
- Support Level
- CLNN $3.30
- CLDI $5.44
- Resistance Level
- CLNN $3.93
- CLDI $7.32
- Average True Range (ATR)
- CLNN 0.23
- CLDI 1.11
- MACD
- CLNN 0.02
- CLDI -0.44
- Stochastic Oscillator
- CLNN 82.61
- CLDI 4.70
About CLNN Clene Inc.
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
About CLDI Calidi Biotherapeutics Inc.
Calidi Biotherapeutics Inc is a clinical-stage immuno-oncology company with technology designed to arm the immune system to fight cancer. The Company's stem cell-based platforms utilize potent allogeneic stem cells capable of carrying payloads of oncolytic viruses for use in a many oncology indications, including high-grade gliomas and solid tumors. Its products include CLD-101 for Recurrent HGG; CLD-201 for Solid Tumors, and CLD-400 for certain lung cancer and Metastatic Solid Tumors. In addition to its pipeline products, the Company's is also engaged in discovery research of CLD-301 (AAA) for tumor Indications.